|
RU2746692C1
|
|
Novel 2-(imidazol-4-yl)-ethanamide pentanedioic-1,5 acid compositions for treating and preventing viral diseases
|
|
RU2744854C1
|
|
Liquid dosage form for treating and preventing influenza and sars
|
|
RU2736713C1
|
|
Combination of mirtazapine and tizanidine for use in pain disorders
|
|
RU2745265C2
|
|
Novel 2-(imidazol-4-yl)-ethanamide of pentandioic-1,5 acid compositions for treating and preventing viral diseases
|
|
RU2733719C1
|
|
Combination for treating functional gastrointestinal diseases
|
|
RU2703293C1
|
|
Liquid dosage form for oral administration, having nootropic activity
|
|
RU2705575C1
|
|
Agent exhibiting hepatoprotective, lipid-regulating, antiischemic and neurotropic activity
|
|
RU2737086C2
|
|
Liquid dosage form for treating and preventing influenza and arvi
|
|
RU2699669C1
|
|
Novel compositions of n-carbamoylmethyl-4-phenyl-2-pyrrolidone
|
|
RU2686066C1
|
|
Sustained release cilostasol dosage form
|
|
RU2701720C1
|
|
Combinations of palmitoylethanolamide for treating chronic pain
|
|
RU2692243C1
|
|
Using lactitol and an oral dosage form for treating and preventing non-alcoholic fatty liver disease
|
|
RU2682966C1
|
|
Buspiron combination for treatment of faintness
|
|
RU2680244C1
|
|
Combination of flupirtine and cyclobenzaprine for treatment of pain syndromes
|
|
RU2680413C1
|
|
Combination of acetylleicine for treatment of dizziness
|
|
RU2706166C2
|
|
Novel polymorphic forms of trimebutine maleate, method for production and use thereof
|
|
RU2693627C2
|
|
Edaravon combination for treating ischemic brain injury
|
|
RU2703729C2
|
|
Combination and kit with anxiolytic action
|
|
RU2688308C2
|
|
Method for diagnosing the severity of functional disorders of the gastrointestinal tract
|
|
RU2696277C2
|
|
N-carbamoylmethyl-4-phenyl-2-pyrrolidone new composition
|
